Literature DB >> 29350312

Genesurance Counseling: Patient Perspectives.

Chelsea Wagner1, Lauren Murphy2, Jacqueline Harkenrider2, Sandra Darilek3, Eleazar Soto-Torres2, Quinn Stein4, Jennifer Hoskovec2.   

Abstract

Genetic counselors (GCs) have reported an increase in discussion of insurance-related, or "genesurance," topics during genetic counseling sessions. Despite increasing frequency, there have been no studies examining patient expectations of GCs in these discussions. This study aimed to explore patient expectations of GCs in these discussions, as well as examine factors that may impact expectations. A 38-item survey was administered prior to patients receiving prenatal or cancer genetic counseling at 11 clinic sites across UTHealth, Baylor College of Medicine, and Sanford Health, with 360 responses analyzed. Key variables were analyzed using descriptive statistics, chi-square analysis, and multivariate logistic regression to assess associations between factors and control for potential confounders. Over 75% of patients expected GCs to discuss genesurance topics during a genetic counseling session. The majority of patients (78%) expected GCs to provide an estimated out-of-pocket cost, know if a test is a covered benefit (77%), and provide referral information for further questions (76%). Two additional expectations, considered to be unrealistic in most clinical settings, included expecting GCs to know the patient's specific insurance plan and coverage information (57%) and provide an exact out-of-pocket cost (41%). Ethnicity was the only significant predictor of response for these two expectations, as African Americans and Hispanics were more likely than Caucasians to have these beliefs. While the patient participants felt that GCs were primarily responsible for initiating these conversations, they also reported a personal sense of responsibility for raising questions. This study demonstrates that patients may expect GCs to address genesurance topics in a genetic counseling session, with specific expectations about the cost and coverage of genetic tests. Further studies will establish the most effective way to communicate this information to patients and examine whether and where within the scope of GC practice, genesurance discussions fall.

Entities:  

Keywords:  Cancer genetic counseling; Genesurance counseling; Genetic counseling; Health insurance; Insurance topics; Patient expectations; Prenatal genetic counseling

Mesh:

Year:  2018        PMID: 29350312     DOI: 10.1007/s10897-018-0211-2

Source DB:  PubMed          Journal:  J Genet Couns        ISSN: 1059-7700            Impact factor:   2.537


  13 in total

1.  Full disclosure--out-of-pocket costs as side effects.

Authors:  Peter A Ubel; Amy P Abernethy; S Yousuf Zafar
Journal:  N Engl J Med       Date:  2013-10-17       Impact factor: 91.245

2.  Overcoming barriers to discussing out-of-pocket costs with patients.

Authors:  Kevin R Riggs; Peter A Ubel
Journal:  JAMA Intern Med       Date:  2014-06       Impact factor: 21.873

3.  Presented Abstracts from the Thirty Fifth Annual Education Conference of the National Society of Genetic Counselors (Seattle, WA, September 2016).

Authors: 
Journal:  J Genet Couns       Date:  2016-12       Impact factor: 2.537

4.  Genetic Counseling Assistants: an Integral Piece of the Evolving Genetic Counseling Service Delivery Model.

Authors:  Sara Pirzadeh-Miller; Linda S Robinson; Parker Read; Theodora S Ross
Journal:  J Genet Couns       Date:  2016-11-10       Impact factor: 2.537

5.  Development of a Streamlined Work Flow for Handling Patients' Genetic Testing Insurance Authorizations.

Authors:  Wendy R Uhlmann; Katie Schwalm; Victoria M Raymond
Journal:  J Genet Couns       Date:  2017-04-24       Impact factor: 2.537

6.  The financial toxicity of cancer treatment: a pilot study assessing out-of-pocket expenses and the insured cancer patient's experience.

Authors:  S Yousuf Zafar; Jeffrey M Peppercorn; Deborah Schrag; Donald H Taylor; Amy M Goetzinger; Xiaoyin Zhong; Amy P Abernethy
Journal:  Oncologist       Date:  2013-02-26

Review 7.  The cost of genetic testing for ocular disease: who pays?

Authors:  Jenina E Capasso
Journal:  Curr Opin Ophthalmol       Date:  2014-09       Impact factor: 3.761

8.  Does poorer familiarity with Medicare translate into worse access to health care?

Authors:  Robert O Morgan; Cayla R Teal; Jennifer C Hasche; Laura A Petersen; Margaret M Byrne; Debora A Paterniti; Beth A Virnig
Journal:  J Am Geriatr Soc       Date:  2008-11       Impact factor: 7.538

9.  Who Pays? Coverage Challenges for Cardiovascular Genetic Testing in U.S. Patients.

Authors:  Katherine G Spoonamore; Nicole M Johnson
Journal:  Front Cardiovasc Med       Date:  2016-05-31

10.  Development of the Health Insurance Literacy Measure (HILM): conceptualizing and measuring consumer ability to choose and use private health insurance.

Authors:  Kathryn A Paez; Coretta J Mallery; HarmoniJoie Noel; Christopher Pugliese; Veronica E McSorley; Jennifer L Lucado; Deepa Ganachari
Journal:  J Health Commun       Date:  2014
View more
  3 in total

Review 1.  Latinx individuals' knowledge of, preferences for, and experiences with prenatal genetic testing: a scoping review.

Authors:  Natalie Grafft; Andrew A Dwyer; María Pineros-Leano
Journal:  Reprod Health       Date:  2022-06-06       Impact factor: 3.355

2.  The impact of the number of tests presented and a provider recommendation on decisions about genetic testing for cancer risk.

Authors:  Marci L B Schwartz; William M P Klein; Lori A H Erby; Christy H Smith; Debra L Roter
Journal:  Patient Educ Couns       Date:  2020-09-18

Review 3.  Genetic counseling in the context of Bangladesh: current scenario, challenges, and a framework for genetic service implementation.

Authors:  Mohammad Jakir Hosen; Saeed Anwar; Jarin Taslem Mourosi; Sourav Chakraborty; Md Faruque Miah; Olivier M Vanakker
Journal:  Orphanet J Rare Dis       Date:  2021-04-09       Impact factor: 4.123

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.